Revlimid
NDC 59572-425, Lenalidomide, capsule, from Celgene Corporation.
- Product NDC
- 59572-425
- Status
- Listed
- Labeler
- Celgene Corporation
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021880
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59572-425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LENALIDOMIDE25 mg/1
Pharmacologic classes
Thalidomide Analog [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59572-425-00 | 59572042500 | 100 CAPSULE in 1 BOTTLE (59572-425-00) |
| 59572-425-21 | 59572042521 | 21 CAPSULE in 1 BOTTLE (59572-425-21) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/5fa97bf5-28a2-48f1-8955-f56012d296be
Use it
Look up 59572-425 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59572-425 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59572-425. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.